{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:54:40Z","timestamp":1793073280459,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013918","name":"Sanfilippo Children's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012233","name":"Abeona Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012233","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Children's Medical Research Foundation"},{"name":"The Sanfilippo Research Foundation"},{"name":"The Sanfilippo Children's Research Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ymgme.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:23:56Z","timestamp":1557401036000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of biomarkers for Sanfilippo syndrome"],"prefix":"10.1016","volume":"128","author":[{"given":"Jennifer T.","family":"Saville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen V.","family":"Truxal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.05.005_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","volume":"3","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2019.05.005_bb0010","first-page":"1","article-title":"Developmental and behavioral aspects of mucopolysaccharideses with brain manifestations - neurological signs and symptoms","volume":"122S","author":"Shapiro","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","article-title":"Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion","volume":"35","author":"Whitley","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.1189","article-title":"Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical and biological implications","volume":"18","author":"Yogalingam","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2019.05.005_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential sub cellular localisation of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0040","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s11064-012-0761-x","article-title":"Abnormal gangliosides are localised in lipid rafts in Sanfilippo (MPS IIIA) mouse brain","volume":"37","author":"Dawson","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0045","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/glycob\/cws103","article-title":"Biosynthesis of the major brain gangliosides GD1a and GT1b","volume":"22","author":"Sturgill","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2019.05.005_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2017.09.006","article-title":"Quantitative neuroimaging in mucopolysaccharidoses clinical trials","volume":"122","author":"Nestrasil","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of muchpolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"Heron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2019.05.005_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2016.08.002","article-title":"A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: implications for clinical trial design","volume":"119","author":"Truxal","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0065","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41436-018-0136-z","article-title":"Disease and subtype specific signatures enable precise diagnosis of the mucopolysaccharidoses","volume":"21","author":"Saville","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF01799255","article-title":"A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type A (MPS IIIA)","volume":"19","author":"Karpova","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1399-0004.1985.tb00217.x","article-title":"4-Methylumbelliferyl \u03b1-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease","volume":"27","author":"Marsh","year":"1985","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0080","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0085","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/jnc.13976","article-title":"Subregional brain distribution of simple and complex glycosphingolipids in the mucopolysaccharidosis type I (Hurler syndrome) mouse: impact of diet","volume":"141","author":"Saville","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0090","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/metabo4041088","article-title":"Distribution of Heparan sulfate oligosaccharides in murine mucopolysaccharidosis Type IIIA","volume":"4","author":"Mason","year":"2014","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgme.2019.05.005_bb0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of mucopolysaccharidosis type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpeds.2018.01.044","article-title":"Observational prospective natural history of patients with Sanfilippo syndrome Type B","volume":"197","author":"Whitley","year":"2018","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0105","doi-asserted-by":"crossref","first-page":"e1255","DOI":"10.1542\/peds.2007-0282","article-title":"Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A)","volume":"120","author":"Meyer","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2019.05.005_bb0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10545-012-9535-5","article-title":"Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease","volume":"36","author":"de Ruijter","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","article-title":"Natural history of Sanfilippo syndrome type A","volume":"37","author":"Buhrman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01804384","article-title":"Sanfilippo B disease: a re-examination of a particular sibship after 12\u202fyears","volume":"14","author":"Di Natale","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ana.25069","article-title":"Prediction of phenotypic severity in mucopolysaccharidosis type IIIA","volume":"82","author":"Knottnerus","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-016-9916-2","article-title":"Residual N-acetyl-\u03b1-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB","volume":"39","author":"Meijer","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0135","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-4159.1980.tb11220.x","article-title":"Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues","volume":"34","author":"Constantopoulos","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0140","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archneur.1980.00500590069012","article-title":"Pathologic findings in mucopolysaccharidosis type IIIB (Sanfilippo\u2019s syndrome B)","volume":"37","author":"Hadfield","year":"1980","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2019.05.005_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibs.2015.03.007","article-title":"Gangliosides: glycosphingolipids essential for normal neural development and function","volume":"40","author":"Schengrund","year":"2015","journal-title":"Trends Biochem. Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219303063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219303063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:13Z","timestamp":1761089113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219303063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1096719219303063"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.05.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of biomarkers for Sanfilippo syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}